Is Merck the Next Big Weight-Loss Stock?
Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the weight-loss drugs market.
Amidst an evolving field of competitors, the big pharma is committing a hearty chunk of cash in hopes of becoming a contender. But will that be enough to make it into the next great weight-loss stock? Let's investigate.
Merck on Dec. 16 said it had just inked a license agreement with a Chinese biopharma company called Hansoh Pharma that could presage its merits as a weight-loss stock in the coming years.
Source Fool.com
Merck KGaA Stock
€128.75
-2.810%
Our community is currently high on Merck KGaA with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 142 € shows a slightly positive potential of 10.29% compared to the current price of 128.75 € for Merck KGaA.
